Breast Cancer

Recurrence Score test may help some women with breast cancer be spared of chemotherapy without experiencing disease progression.

Evista is typically given to women after menopause to treat and prevent osteoporosis and reduce the risk of invasive breast cancer.

New treatment approach offers less severe side effects from chemotherapy.

Study finds incidence of post-traumatic stress symptoms in breast cancer patients to be underestimated.

Alcohol can affect estrogen in breast cancer cells and weakens the ability of drugs that halt proliferation.

Advocacy group helps breast cancer patient overcome fear and channel her anger to battle the disease.

Tyverb and Herceptin combination shows significant promise treating HER2 positive breast cancer.

Increased inflammation in obese women is thought to increase the risk of breast cancer.

New analysis provides faster tests and lower costs for women with estrogen positive-receptor (ER-positive) breast cancer.

Nanoparticles acting as cancer drug delivery vehicles show promise in eliminating tumors.

Several chemotherapy agents have been investigated for neoadjuvant use in HER2-positive breast cancer.

The management of individual chemotherapy regimens by pharmacists improves safety by reducing medication errors.

Proposal includes giving insurers the ability to withhold products from formularies if the cost of cancer drugs do not represent good value.

Palbociclib (Ibrance) approved for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Ibrance approved for the treatment of HR+, HER2- advanced or metastatic breast cancer.

Antibody-drug conjugates and immunotherapy harness immune system to target breast cancer tumors.

Investigators seek to stop women's cancers before it starts to form.

Emend found to provide a greater delay in nausea and vomiting from cancer treatment than other medicines.

Emend found to provide a greater delay in nausea and vomiting from cancer treatment than other medicines.

Early detection is key in reducing the risk of heart failure in patients with cancer.

New research may transform oncology drug development.

Researchers warn political interference may discourage shared decision-making in breast cancer treatment.

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Researchers examine how genetic changes in breast cancer cells interfere with pathways critical to disease growth and survival.